BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld
Home
» Other news to note for April 26, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full article
sign up for free
or
sign in
.
Other news to note for April 26, 2021
April 26, 2021
No Comments
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advaxis, Asher, Ashvattha, Biontech, BMS, Boston, Bugworks, Carisma, Cybin, Daiichi Sankyo, Evotec, Geneleap, GW, Immunome, Jazz, Johnson & Johnson, Landos, Lantern, Leading, Moderna, OS Therapies, Palisades, Pieris, Probiogen, Psybio, RDIF, Samsung, Sanofi, Seneca, TG, Therapeutic Solutions, Viscoran.
BioWorld
Briefs
Other news to note
Coronavirus